You have 9 free searches left this month | to do more
Showing 1 - 25 of
4,593 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • brentuximab vedotin
  • Anaheim, California
  • +18 more
2021-12-10
Dec 10, 2021
S
Recruiting
  • Hodgkin Disease
  • Peripheral T Cell Lymphoma
  • brentuximab vedotin
  • +3 more
  • Birmingham, Alabama
  • +53 more
2021-10-29
Oct 29, 2021
N
Active, not recruiting
  • Lymphoma, Large-Cell, Anaplasitc
  • +4 more
  • Anti-CD30-CAR T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-02
Sep 2, 2021
A
Recruiting
  • Peripheral T Cell Lymphoma
  • Transformed Mycosis Fungoides
  • Birmingham, Alabama
  • +68 more
2022-01-03
Jan 3, 2022
Y
Not yet recruiting
  • PTLD
  • +8 more
  • New Haven, Connecticut
  • +1 more
2021-10-28
Oct 28, 2021
T
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021
T
Recruiting
  • Hodgkin Lymphoma, Adult
  • +3 more
  • Duarte, California
  • +4 more
2021-03-22
Mar 22, 2021
U
Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-12-02
Dec 2, 2021
T
Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Pediatric Hodgkin Lymphoma
  • Brentuximab Vedotin (Genetical Recombination)
  • Tokyo, Japan
    Takeda Selected Site
2021-09-29
Sep 29, 2021
C
Active, not recruiting
  • Adult T-Cell Leukemia/Lymphoma
  • +10 more
  • Brentuximab Vedotin
  • +7 more
  • Duarte, California
  • +4 more
2021-08-10
Aug 10, 2021
B
Recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin Lymphoma
  • CAR T Cells
  • +2 more
  • Houston, Texas
  • +1 more
2021-11-02
Nov 2, 2021
U
Recruiting
  • Peripheral T Cell Lymphoma
  • ATLCAR.CD30 T cells
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
2021-12-20
Dec 20, 2021
U
No longer available
  • Hodgkin Lymphoma, Adult
  • ATLCAR.CD30
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-12-02
Dec 2, 2021
N
Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • +2 more
  • Brentuximab Vedotin
  • Placebo
  • Los Angeles, California
  • +9 more
2021-04-09
Apr 9, 2021
C
Not yet recruiting
  • Lymphoma, T-Cell, Peripheral
  • Adcetris 50 MG Injection
  • +4 more
  • Brno, Czechia
  • +6 more
2021-08-26
Aug 26, 2021
F
Recruiting
  • Hodgkin Lymphoma, Adult
  • T Cell Lymphoma
  • HSP-CAR30
  • Barcelona, Spain
    Hospital Santa Creu i Sant Pau
2020-11-30
Nov 30, 2020
U
Recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-14
Dec 14, 2021
F
Active, not recruiting
  • Lymphatic Diseases
  • Brentuximab Vedotin
  • Bologna, Italy
  • +3 more
2021-12-17
Dec 17, 2021
B
Not yet recruiting
  • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
  • Classical Hodgkin Lymphoma
  • CD30.CAR-EBVST cells
  • Houston, Texas
  • +1 more
2021-06-28
Jun 28, 2021
U
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • CAR.CD30 T cells
  • Chapel Hill, North Carolina
  • +2 more
2021-07-04
Jul 4, 2021
B
Active, not recruiting
  • Non-Hodgkin's Disease
  • Nivolumab
  • Brentuximab Vedotin
  • Birmingham, Alabama
  • +26 more
2020-03-23
Mar 23, 2020
U
Recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • BeEAM Regimen
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
2021-07-29
Jul 29, 2021
B
Recruiting
  • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
  • Classical Hodgkin Lymphoma
  • CD30.CAR-EBVST cells
  • Houston, Texas
  • +1 more
2021-03-30
Mar 30, 2021
U
Recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
2021-08-12
Aug 12, 2021
L
Not yet recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab vedotin
  • (no location specified)
2021-11-24
Nov 24, 2021